<TABLE>
<S> <C>
OMB Approval
UNITED STATES OMB Number: 3235-0145
SECURITIES AND EXCHANGE COMMISSION Expires: December 31, 1997
Washington, D.C. 20549 Estimated average burden
hours per response.....14.90
</TABLE>
Schedule 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
The Med-Design Corporation
--------------------------
(Name of Issue)
Common Stock
-----------------------------
(Title of Class of Securities)
583926 10 0
--------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement ____. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to subject class of securities, and for
any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SEC1745 (2-95) Page 1 of 4
<PAGE>
CUSIP NO. 583926 10 0 13G PAGE 2 OF 4 PAGES
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Michael Botich
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
A ____
N/A B ____
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
5. SOLE VOTING POWER
401,592 Shares of Common Stock (includes stock options to purchase
2,000 shares)
6. SHARED VOTING POWER
N/A
7. SOLE DISPOSITIVE POWER
401,592 Shares of Common Stock (includes stock options to purchase
2,000 shares)
8. SHARED DISPOSITIVE POWER
N/A
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
401,592 Shares of Common Stock (includes stock options to purchase
2,000 shares)
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.8%
12. TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILING OUT!
SEC1745 (2-95) Page 2 of 4
<PAGE>
CUSIP No. 583926 10 0 13G Page 3 of 4 Pages
Item 1. The issuer of the securities to which this statement relates is The
Med-Design Corporation ("Med-Design"). Med-Design's principal
executive offices are located at the North American Building, Suite
310, 121 South Broad Street, Philadelphia, Pennsylvania 19107.
Item 2. This statement is filed by Michael Botich, a citizen of the United
States of America, whose business address is c/o MDC Research Ltd.,
2810 Bunsen Avenue, Ventura, California 93003. The title of the class
of securities to which this statement relates is Common Stock, having
a CUSIP number of 583926 10 0.
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b),
check whether the person filing is a:
N/A
Item 4. Ownership
See item nos. 5 through 11 on the second part of the cover sheet.
Item 5. Ownership of Five Percent or Less of a Class
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another Person
N/A
Item 7. Identification and Classification of the Subsidiary which Acquired the
Security Being Reported on by the Parent Holding Company
N/A
Item 8. Identification and Classification of Members of the Group
N/A
Item 9. Notice of Dissolution of Group
N/A
Item 10. Certification
N/A
SEC1745 (2-95) Page 3 of 4
<PAGE>
CUSIP No. 583926 10 0 13G Page 4 of 4 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
-----------------------------------
Date
/s/ Michael Botich
-----------------------------------
Signature
Michael Botich
Senior Vice President, R&D
-----------------------------------
Name/Title
SEC1745 (2-95) Page 4 of 4
